FOLH1 and posterior cortical atrophy: Conversely, Hagens et al. [15], in a study of 396 patients with newly diagnosed unfavorable intermediate-risk PCa, found a PSMA PET positivity rate of 9.3% for both lymph node and distant metastases but did not report diagnostic performance data.